Exact Sciences Corporation vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
4.7
Bearish
Overall
6.3
Neutral
Quality
Health
Growth
Valuation
Sentiment
EXAS
Healthy balance sheet and financial position.
⚠ currently unprofitable (-6% margin).
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
HOLD
Target $106.30 (+1.3%)
10 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
EXAS
UNH
—
Trailing P/E
27.9×
55.2×
Forward P/E
17.8×
-6.4%
Profit Margin
2.7%
69.7%
Gross Margin
18.8%
-8.7%
ROE
12.2%
23.1%
Revenue Growth
2.0%
—
Earnings Growth
0.7%
1.44
Beta
0.41
—
Price / Book
—
$20.0B
Market Cap
$334.9B
$39 – $105
52-Week Range
$235 – $410
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →